IVD Raw Materials Market Overview, Key Trends, and Top Player Analysis

The in vitro diagnostics (IVD) raw materials sector is positioned for rapid expansion as advances in medical technology and growing healthcare demands continue to evolve. Understanding the market's projected growth, key players, current trends, and segmentation offers valuable insight into this critical industry supporting diagnostic innovation worldwide.

Projected Market Size and Growth Trajectory for the IVD Raw Materials Market
The IVD raw materials market is anticipated to experience robust growth, reaching a value of $43.76 billion by 2030 with a compound annual growth rate (CAGR) of 9.8%. This expansion is driven by several factors, including a rising prevalence of chronic and infectious diseases, increased investments in precision diagnostics, growth in point-of-care testing, and an upsurge in biopharmaceutical research and development activities. Additionally, there is a growing demand for customized IVD raw materials. Key market trends that will influence growth include heightened demand for high-purity diagnostic reagents, increased adoption of recombinant antibodies and proteins, expanded use of molecular diagnostics consumables, a focus on quality and batch consistency, and strategic diversification of supply chains for essential IVD inputs.

Download a free report of the ivd raw materials market report:
https://www.thebusinessresearchcompany.com/report/ivd-raw-materials-global-market-report?utm_source=OpenPR&utm_medium=Paid&utm_campaign=Apr_PR

Emerging Leaders in the IVD Raw Materials Industry
Prominent companies shaping the IVD raw materials market include Merck KGaA, Thermo Fisher Scientific Inc., Bio-Rad Laboratories Inc., LGC Limited, Neogen Corporation, MP Biomedicals, CUSABIO Technology, Fujirebio, Fapon Biotech, ABclonal Technology, Creative Diagnostics, AIVD Biotech Inc., OPERON, Beijing Diagreat Biotechnology Co. Ltd., Biosynth, Aalto Bio Reagents, Angstrom Biotech, Eximio Biotech, Glentham Life Sciences Limited, OYC Americas Inc., NOVA Biologics Inc., Sino Biological Inc., ACROBiosystems, and ProSpec-Tany TechnoGene Ltd. A notable recent development occurred in June 2025, when Fujirebio Holdings, Inc., a Japan-based IVD and life-science technology firm, acquired Plasma Services Group, Inc. This acquisition aims to strengthen Fujirebio's supply chain and position it as a reliable provider of rare and critical biological raw materials globally. Plasma Services Group specializes in collecting, screening, and supplying high-quality biological materials such as sera and other samples essential for control reagents and calibrators, operating from its FDA-registered and ISO-certified facility in Moorestown, NJ.

Key Trends Influencing the IVD Raw Materials Market
Companies within the patient positioning systems segment are increasingly developing single-camera unit solutions to boost accuracy, simplify workflows, and enhance patient safety during medical procedures. A single-camera unit setup captures all necessary angles and perspectives with one camera, reducing complexity and improving efficiency. For example, in May 2023, BLI-BRAIN LAB INDIA introduced ExacTrac Dynamic Surface, a system using a unique single-camera design that continuously monitors patients' positions during treatment without obstruction from the treatment gantry. This advancement highlights the focus on integrating streamlined technology in diagnostics to support precise medical interventions.

View the full ivd raw materials market report:
https://www.thebusinessresearchcompany.com/report/ivd-raw-materials-global-market-report?utm_source=OpenPR&utm_medium=Paid&utm_campaign=Apr_PR

Breakdown of Segments in the IVD Raw Materials Market
The IVD raw materials market is segmented by product, technology, and end user to provide a detailed overview:
1) Product categories include Antibodies, Antigens, Enzymes, Proteins, and Biological Buffers.
2) Technology segments cover Molecular Diagnostics, Clinical Chemistry, and Immunochemistry.
3) End users comprise Pharmaceutical and Biotechnology Companies as well as Contract Research Organizations.

Further subcategories within these segments include:
- Antibodies: Monoclonal, Polyclonal, and Recombinant types
- Antigens: Recombinant, Native, and Synthetic varieties
- Enzymes: Polymerases, Reverse Transcriptases, and Oxidases
- Proteins: Carrier Proteins, Blocking Proteins, and Recombinant Proteins
- Biological Buffers: Tris Buffers, HEPES Buffers, and Phosphate Buffers

This structured segmentation helps to clarify the diverse range of raw materials and technologies vital to supporting the expanding IVD industry.

Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.